Benefits of clopidogrel in patients undergoing coronary stenting significantly depend on loading dose: Evidence from a meta-regression

This publication has 44 references indexed in Scilit:

• A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease
  European Heart Journal, 2006
• Validation of Predictors of Intraprocedural Stent Thrombosis in the Drug-Eluting Stent Era
  The American Journal of Cardiology, 2005
• Long-term benefits of an early invasive management in acute coronary syndromes depend on intracoronary stenting and aggressive antiplatelet treatment: A metaregression
  American Heart Journal, 2005
• Cilostazol, clopidogrel or ticlopidine to prevent sub-acute stent thrombosis: A meta-analysis of randomized trials
  American Heart Journal, 2004
• A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary artery stents
  Journal of the American College of Cardiology, 2003
• How should meta‐regression analyses be undertaken and interpreted?
  Statistics in Medicine, 2002
• Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting
  Journal of the American College of Cardiology, 2001
• Ticlopidine and Clopidogrel
  Circulation, 1999
• A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery Stenting
  New England Journal of Medicine, 1998
• Intracoronary Stenting Without Anticoagulation Accomplished With Intravascular Ultrasound Guidance
  Circulation, 1995